Although we analyzed only CD44v6 among the carcinoma-associated variants of CD44, our data suggested the interaction between EpCAM and the other carcinoma-associated variants of CD44 in thyroid cancer as well. This evidence concerns the gene EPCAM and thyroid gland carcinoma.